GCM
NOVT icon

Geneva Capital Management’s Novanta NOVT Stock Holding History

Geneva Capital Management’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123M Sell
758,878
-172,392
-19% -$24.9M 2.82% 6
2026
Q1 		$110M Buy
931,270
+28,182
+3% +$3.7M 2.34% 11
2025
Q4 		$107M Sell
903,088
-75,950
-8% -$8.65M 2.02% 15
2025
Q3 		$98.1M Sell
979,038
-9,931
-1% -$1.18M 1.68% 17
2025
Q2 		$128M Buy
988,969
+54,934
+6% +$6.69M 2.14% 13
2025
Q1 		$119M Buy
934,035
+81,397
+10% +$11.7M 2.23% 15
2024
Q4 		$130M Buy
852,638
+72,592
+9% +$12.3M 2.26% 12
2024
Q3 		$140M Buy
780,046
+8,574
+1% +$1.49M 2.33% 10
2024
Q2 		$126M Sell
771,472
-5,829
-0.7% -$946K 2.29% 10
2024
Q1 		$136M Sell
777,301
-4,040
-0.5% -$663K 2.39% 8
2023
Q4 		$132M Buy
781,341
+66,633
+9% +$9.71M 2.48% 6
2023
Q3 		$103M Buy
714,708
+60,033
+9% +$9.78M 2.16% 10
2023
Q2 		$121M Sell
654,675
-1,452
-0.2% -$238K 2.38% 8
2023
Q1 		$104M Buy
656,127
+7,683
+1% +$1.18M 2.13% 10
2022
Q4 		$88.1M Buy
648,444
+628
+0.1% +$87.9K 1.98% 10
2022
Q3 		$74.9M Buy
647,816
+25,630
+4% +$3.49M 1.73% 14
2022
Q2 		$75.5M Buy
622,186
+47,720
+8% +$6M 1.74% 15
2022
Q1 		$81.7M Buy
574,466
+39,922
+7% +$5.66M 1.58% 16
2021
Q4 		$94.3M Sell
534,544
-11,489
-2% -$1.92M 1.52% 19
2021
Q3 		$84.4M Sell
546,033
-3,902
-0.7% -$567K 1.43% 22
2021
Q2 		$74.1M Sell
549,935
-9,145
-2% -$1.23M 1.21% 31
2021
Q1 		$73.7M Sell
559,080
-12,358
-2% -$1.62M 1.26% 27
2020
Q4 		$67.6M Buy
571,438
+16,513
+3% +$1.93M 1.14% 31
2020
Q3 		$58.5M Buy
554,925
+14,336
+3% +$1.52M 1.21% 26
2020
Q2 		$57.7M Buy
540,589
+100,376
+23% +$9.33M 1.25% 26
2020
Q1 		$35.2M Buy
+440,213
New +$39.3M 1% 43

Other funds holding NOVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Geneva Capital Management's NOVT Position: Q2 2026 in Review

Geneva Capital Management reduced its Novanta (NOVT) stake by 19% in Q2 2026, selling an estimated $24.9M and leaving 758,878 shares worth $123M. The position accounts for 2.82% of the portfolio, ranked #6.

Geneva Capital Management first reported a position in NOVT in Q1 2020 and has held it in 26 quarters since. The position peaked at $140M in Q3 2024. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • Geneva Capital Management held 758,878 shares of Novanta worth $123M as of Q2 2026.
  • Geneva Capital Management sold 172,392 Novanta shares in Q2 2026, an estimated $24.9M.
  • Novanta made up 2.82% of Geneva Capital Management's portfolio in Q2 2026, its #6 holding.
  • Geneva Capital Management first reported a position in Novanta in Q1 2020 and has held it in 26 quarters since.
  • Geneva Capital Management's Novanta position peaked at $140M in Q3 2024.
  • 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.